Dr. Reddy’s launches ‘Redispar™’ in India
Dr. Reddy’s Laboratories Ltd. launched Redispar™ (Doxercalciferol) in India. Used in the treatment of secondary hyperparathyroidism (SHPT) due to chronic kidney disease, Redispar™ is the first pro-vitamin D2 to be available in the country.
Redispar™ is used to maintain the parathyroid hormone (PTH) and calcium levels in the body in chronic kidney disease patients. Doxercalciferol is safer and more effective in comparison to Calctirol (vitamin D3) and Alfacalcidol (pro vitamin D3).
It is available in soft gelatin capsule form, and in dosages of 0.5mcg and 2.5mcg.
Source: Dr. Reddy’s